PSMA expression in the Hi‐Myc model; extended utility of a representative model of prostate adenocarcinoma for biological insight and as a drug discovery tool

Prostate‐specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II (GCPII), is highly overexpressed in primary and metastatic prostate cancer (PCa). This has led to the development of radiopharmaceuticals for targeted imaging and therapy under current clinical evaluation. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Simons, Brian W., Turtle, Norman F., Ulmert, David H., Abou, Diane S., Thorek, Daniel L. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Rapid Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519119/
https://www.ncbi.nlm.nih.gov/pubmed/30656716
http://dx.doi.org/10.1002/pros.23770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519119/
https://www.ncbi.nlm.nih.gov/pubmed/30656716
http://dx.doi.org/10.1002/pros.23770

Ejemplares similares